ORIGINAL ARTICLE
Year : 2016  |  Volume : 18  |  Issue : 6  |  Page : 942-945

Healthcare utilization and costs in patients with benign prostatic hyperplasia: a population-based study


1 Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan, China
2 School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan, China
3 Sleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan, China
4 Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan, China
5 Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan, China
6 School of Public Health, Taipei Medical University, Taipei, Taiwan, China

Correspondence Address:
Chao-Yuan Huang
Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan, China; School of Public Health, Taipei Medical University, Taipei, Taiwan, China

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1008-682X.167718

Rights and Permissions

This study aimed to investigate differences in healthcare service utilization between patients with and those without benign prostatic hyperplasia (BPH) using Taiwan's National Health Insurance population-based database. A total of 7413 patients with BPH and 7413 age-matched patients without BPH were included. The outcome variable was 1-year utilization of healthcare services including the number of outpatient visits, inpatient days, and the costs of outpatient and inpatient treatments. In addition, we separated healthcare services into urology services and nonurology services for analysis. We found that as to the utilization of outpatient urological services, patients with BPH had more outpatient services (7.84 vs 0.52, P< 0.001), higher outpatient costs (US$372 vs US$34, P< 0.001), a longer length of inpatient stay (0.55 vs 0.11, P< 0.001), higher in-patients costs (US$149 vs US$32, P< 0.001), and higher total costs (US$521 vs US$67, P< 0.001) than the comparison group. As for nonurological services, patients with BPH also had more outpatient services (49.11 vs 24.79, P< 0.001), higher outpatient costs (US$1794 vs US$1014, P< 0.001), a longer length of in-patient stay (3.72 vs 2.04, P< 0.001), higher inpatient costs (US$874 vs US$486, P< 0.001), and higher total costs (US$2668 vs US$1500, P< 0.001) compared to comparison patients. We also found that the average total cost was about 2-fold greater for patients with BPH than comparison patients. We concluded that patients with BPH had higher healthcare utilization than comparison patients without BPH.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3088    
    Printed125    
    Emailed0    
    PDF Downloaded388    
    Comments [Add]    

Recommend this journal